Personal and Home Care Products
CIRS Group
Medical Devices
C&K Testing
Carbon Neutrality

SCCS Issued Final Opinion on the Safety of Alpha-Arbutin and Beta-Arbutin

from CIRS by

On February 1, 2023, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued the final opinion on α-arbutin and β-arbutin. The preliminary opinion on the safety of arbutin in cosmetics (SCCS/1642/22) was released on March 15, 2022.


The final conclusion is as follows:

  • SCCS believes that the maximum safe concentration of α-arbutin in face cream is 2% and the maximum safe concentration of α-arbutin in body milk is 0.5%. It is safe when used together.
  • The maximum safe concentration of β-arbutin in face cream is 7%.
  • Hydroquinone should remain as low as possible in formulations containing alpha-or beta-arbutin and should not be higher than the unavoidable traces in both arbutins. In the new studies, submitted by the applicant, 3 parts per million (ppm) was the limit of quantification (LOQ) for hydroquinone and 1ppm for the limit of detection (LOD).
  • Aggregate exposure of alpha-arbutin (2% in face cream and 0.5% in body lotion) with beta-arbutin (7% in face cream) is considered safe. It is worth noting that SCCS is temporarily unable to conclude α- Arbutin and β- The maximum safe concentration limit of arbutin in cosmetics.

If you have any needs or questions, please contact us at

Further Information

SCCS - Final Opinion on the safety of alpha-arbutin and beta-arbutin in cosmetic products



We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.